RejuvenAir® System Trial for COPD With Chronic Bronchitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The RejuvenAir® System is a cryosurgical device that applies medical‐grade liquid nitrogen to the treatment area via a radial head catheter in a small, accurately directed spray. Cryotherapy with the RejuvenAir® System is designed to induce a regenerative endobronchial tissue effect by: 1) destroying via cryotherapy the abnormal surface epithelium that has become overgrown with mucin producing goblet cells, 2) thus allowing normal bronchial epithelium with a regrowth of ciliated epithelial cells that will facilitate the removal of mucins from the bronchial airways and 3) lead to a reduction in chronic inflammation and its accompanying mucosal swelling with resultant increase in the treated airway diameter. This reversal of inflamed epithelium may also lessen systemic inflammation.
Epistemonikos ID: 3db9560899b44d511efaf8bfd2fab02853f2d19a
First added on: May 22, 2024